Skip to main content
Premium Trial:

Request an Annual Quote

TriLink Biotech Names Australian Distributor

Premium

TriLink Biotechnologies said today that it has entered into a distribution agreement with Australia's Astral Scientific.

Terms of the agreement call for Astral to sell San Diego-based TrLink's modified nucleic acid products, including more than 150 modified nucleotides, custom oligonucleotides, and CleanAmp Hot Start PCR products.

Astral, based in the Sydney area, supplies the clinical diagnostics, life science research, and industrial markets.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.